Identifying the causal role and therapeutic potential of immune-related genes in bladder cancer: a Mendelian randomization study
This study elucidates the immune-related pathways influencing bladder cancer, highlighting GSTM1 and other key immune-related genes as potential biomarkers. These discoveries pave the way for innovative therapeutic approaches, advancing personalized medicine strategies in bladder cancer treatment.
Authors
- Le Kang (ORCID: https://orcid.org/0000-0002-2730-4229)
- Lin Li (ORCID: https://orcid.org/0000-0002-3659-7529)
- Yonggang Chen (ORCID: https://orcid.org/0000-0001-6109-8767)
- Qingfeng Yu (ORCID: https://orcid.org/0000-0001-7316-627X)
- Xiaomei Jiang
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Loudi Central Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1007/s12672-025-03806-3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00